Hero Backgroundrounded-top
rounded-bottom

Desvenlafaxine Succinate (CAS NO : 93413-62-8)

Desvenlafaxine Succinate is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat major depressive disorder (MDD) in adults. It is the active metabolite of venlafaxine, another antidepressant, and works by increasing the levels of serotonin and norepinephrine in the brain, which helps regulate mood. It is a metabolite of the drug venlafaxine. It has a role as a marine xenobiotic metabolite, a drug metabolite and an antidepressant. This api is EU approved in Spain (2012) and Germany (2022). Also (FDA) Approved for major depressive disorder in adults.

Desvenlafaxine Succinate
Desvenlafaxine Succinate

Desvenlafaxine Succinate is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat major depressive disorder (MDD) in adults. It is the active metabolite of venlafaxine, another antidepressant, and works by increasing the levels of serotonin and norepinephrine in the brain, which helps regulate mood. It is a metabolite of the drug venlafaxine. It has a role as a marine xenobiotic metabolite, a drug metabolite and an antidepressant. This api is EU approved in Spain (2012) and Germany (2022). Also (FDA) Approved for major depressive disorder in adults.

Industries 1Industries

Industry

Pharmaceutical

Category 1Category

Category

Pharmaceutical Actives & Precursors

Sub-categorySub-category 1

Sub-category

Active Pharmaceutical Ingredients (APIs)

Get a Quote

Details included in quote

Minimum Order Quantity

Lead Time

Regional Availability

Incoterms

Intersect 1
Rounded Top

Chemical Properties & Specifications

Applications of Desvenlafaxine Succinate

Major Depressive Disorder (MDD)

Desvenlafaxine Succinate is prescribed for the treatment of MDD in adults. It helps alleviate symptoms such as persistent feelings of sadness, loss of interest in daily activities, and fatigue.

End Use Pharmaceutical Formulations

Incorporated into oral dosage forms, specifically extended-release tablets, to ensure consistent delivery of the medication over time. Common strengths include 25 mg, 50 mg, and 100 mg tablets.

Have Questions About Desvenlafaxine Succinate?
We've Got Answers.

Get a Quote

Get a Quote